Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;30(10):497-8.
doi: 10.1016/j.tibtech.2012.06.002. Epub 2012 Jul 11.

The synthetic futures of vesicular stomatitis virus

Christopher Overend, Lijuan Yuan, Jean Peccoud

The synthetic futures of vesicular stomatitis virus

Christopher Overend et al. Trends Biotechnol. 2012 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Logical representation of the vesicular stomatitis virus (VSV) genome structure. The natural VSV genome (a) is composed of five open reading frames bounded by a 3′ leader sequence (Le) and a 5′ trailer region (Tr). Sequences coding for foreign antigens can be inserted in 3′ of the nucleoprotein (N) gene and between the glycoprotein (G) and large polymerase protein (L) genes. These locations are indicated by broken lines in (a). The Ebola vaccine was designed by replacing the VSV G protein with the Ebola G protein, leading to a replicating pseudotyped vector (b). Similarly, a severe acute respiratory syndrome (SARS) vaccine was designed by replacing the VSV G protein with the SARS spike (S) protein (c). The avian influenza vaccine relies on the insertion of a sequence coding for the H5 antigen immediately next to the leader sequence (d). Interestingly, the booster vaccine carries a different variant of the VSV G protein to escape the anti-VSV immune response acquired during the primary immunization. The tuberculosis vaccine relies on the insertion of an antigen between G and L (e). The Yersinia pestis vaccine is structurally comparable to the avian influenza vaccine (f). Finally, the anti-inflammatory oncolytic VSV has a large insert between G and L. The insert includes an anti-inflammatory glycoprotein (EHV1G) and a reporter gene (Luc) separated by an internal ribosome entry site (IRES) (g). These logical maps were generated using GenoCAD .
See this image and copyright information in PMC

References

    1. Wimmer E. Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat. Biotechnol. 2009;27:1163–1172. - PMC - PubMed
    1. Lichty B.D. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol. Med. 2004;10:210–216. - PubMed
    1. Geisbert T.W. Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog. 2008;4:e1000225. - PMC - PubMed
    1. Schwartz J.A. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J. Virol. 2010;84:4611–4618. - PMC - PubMed
    1. Roediger E.K. Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine. Mol. Ther. 2008;16:1161–1169. - PMC - PubMed

Publication types